 |
Ben Butkus is senior editor of GenomeWeb's premium content and the editor of PCR Insider. He covers technologies and trends in PCR, qPCR, nucleic acid amplification, and sample prep. E-mail Ben Butkus or follow his GenomeWeb Twitter account at @PCRInsider. |
Bio-Rad Life Sciences Q2 Revenues Drop 4 Percent; Digital PCR Sales Slower than Anticipated
August 09, 2012
Bio-Rad Life Sciences Q2 Revenues Drop 4 Percent; Digital PCR Sales Slower than Anticipated
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Digital PCR Sales Contribute to Record Q4 Revenues for Bio-Rad's Life Sciences Segment
February 28, 2013 / PCR Insider - Bio-Rad Doubles Q3 Digital PCR Sales Over Q2; Execs Project Strong Uptake in Future Quarters
November 8, 2012 / PCR Insider - Harvard Group Using Bio-Rad Digital PCR System as Part of NHGRI-Funded Study of Multi-Allelic CNV
August 23, 2012 / PCR Insider - Trovagene Using Bio-Rad Digital PCR System for Trans-Renal Pancreatic Cancer MDx
May 31, 2012 / PCR Insider - Trovagene Bets on Digital PCR as Detection Technology for Urine-Based MDx Testing Platform
May 3, 2012 / PCR Insider